Correction to: BMC Health Serv Res (2018) 18:393
https://doi.org/10.1186/s12913-018-3162-2
In the original publication of this article [1], the Acknowledgements section lacks of important funding information “This project was funded by the NIHR Oxford Biomedical Research Centre BRC”. The authors apologize for any inconvenience that it may have caused.
Reference
Morrell, et al. Will the reformed Cancer drugs fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals. BMC Health Serv Res. 2018;18(393). https://doi.org/10.1186/s12913-018-3162-2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Morrell, L., Wordsworth, S., Schuh, A. et al. Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals. BMC Health Serv Res 19, 198 (2019). https://doi.org/10.1186/s12913-019-4039-8
Published:
DOI: https://doi.org/10.1186/s12913-019-4039-8